www.kempharm.com/pages/pipeline/index.php
www.nasdaq.com/de/symbol/kmph/real-time
Aktuell: $4.8899
*
0.5799
13.45%
www.nasdaq.com/de/symbol/kmph/real-time
Aktuell: $4.8899
*
0.5799
13.45%
|
42 Beiträge ausgeblendet. |
|
$KMPH Key take aways.
1. 132 mil in cash with 1.5 mil/Quarter burn rate
2. Scripts written for both Apadaz and Azstarys. And expanding. Might not be huge but next earnings we have drug revenue.
3. Gonna have a bunch of data on SDX soon and what it could do.
4. They are open to acquisitions and licensing internal products.
5. They plan on being a multi billion dollar company.
6. No current plan for dilution but open if it drives value.
7. Should be getting more analysis on stock soon.
All I smell is Money. May take a few months but we will soon be rewarded for holding. Tutes are gonna want in.
KemPharm kauft Assets von Orphazyme
investors.kempharm.com/news-releases/...arimoclomol-orphazyme
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
67 | KEMPHARM a buy ? | Balu4u | Vassago | 22.02.23 15:00 |